Found: 11
Select item for more details and to access through your institution.
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of age and race on quality of life in young breast cancer survivors.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model.
- Published in:
- Head & Neck, 2011, v. 33, n. 3, p. 349, doi. 10.1002/hed.21455
- By:
- Publication type:
- Article
Assessing patients' risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?
- Published in:
- Cancer Medicine, 2015, v. 4, n. 8, p. 1153, doi. 10.1002/cam4.454
- By:
- Publication type:
- Article
A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e53, doi. 10.1016/j.clml.2019.09.081
- By:
- Publication type:
- Article
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).
- Published in:
- 2017
- By:
- Publication type:
- journal article
An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 17, p. 4098, doi. 10.1002/cncr.26730
- By:
- Publication type:
- Article
Hot Flashes: A Review of Pathophysiology and Treatment Modalities.
- Published in:
- Oncologist, 2011, v. 16, n. 11, p. 1658, doi. 10.1634/theoncologist.2011-0174
- By:
- Publication type:
- Article